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Summary
Genomic structural variants (SVs) are abundant in humans, differing from other variation classes 
in extent, origin, and functional impact. Despite progress in SV characterization, the nucleotide 
resolution architecture of most SVs remains unknown. We constructed a map of unbalanced SVs 
(i.e., copy number variants) based on whole genome DNA sequencing data from 185 human 
genomes, integrating evidence from complementary SV discovery approaches with extensive 
experimental validations. Our map encompassed 22,025 deletions and 6,000 additional SVs, 
including insertions and tandem duplications. Most SVs (53%) were mapped to nucleotide 
resolution, which facilitated analyzing their origin and functional impact. We examined numerous 
whole and partial gene deletions with a genotyping approach and observed a depletion of gene 
disruptions amongst high frequency deletions. Furthermore, we observed differences in the size 
spectra of SVs originating from distinct formation mechanisms, and constructed a map constructed 
a map of SV hotspots formed by common mechanisms. Our analytical framework and SV map 
serves as a resource for sequencing-based association studies.
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Introduction
Unbalanced structural variants (SVs), or copy number variants (CNVs), involving large-
scale deletions, duplications, and insertions form one of the least well studied classes of 
genetic variation. The fraction of the genome affected by SVs is comparatively larger than 
that accounted for by single nucleotide polymorphisms1 (SNPs), implying significant 
consequences of SVs on phenotypic variation. SVs have already been associated with 
diverse diseases, including autism2,3, schizophrenia4,5 and Crohn’s disease6,7. 
Furthermore, locus-specific studies suggest that diverse mechanisms may form SVs de novo, 
with some mechanisms involving complex rearrangements resulting in multiple 
chromosomal breakpoints8,9.
Initial microarray-based SV surveys focused on large gains and losses10,11,12, with recent 
advances in array technology widening the accessible size spectrum towards smaller 
SVs1,13. Microarray-based commonly mapped SVs to approximate genomic locations. 
However, a detailed SV characterization, including analyses of SV origin and impact, 
requires knowledge of precise SV sequences. Advances in sequencing technology have 
enabled applying sequence-based approaches for mapping SVs at fine-
scale14,15,16,17,18,19,20,21. These approaches include: (i) paired-end mapping (or read 
pair ‘RP’ analysis) based on sequencing and analysis of abnormally mapping pairs of clone 
ends14,22,23,24 or high-throughput sequencing fragments15,17,18; (ii) read-depth (‘RD’) 
analysis, which detects SVs by analyzing the read depth-of-coverage16,21,25,26,27; (iii) 
split-read (‘SR’) analysis, which evaluates gapped sequence alignments for SV 
detection28,29; and (iv) sequence assembly (‘AS’), which enables the fine-scale discovery 
of SVs, including novel (non-reference) sequence insertions30,31,32. Sequence-based SV 
discovery approaches have thus far been applied to a limited (<20) number of genomes, 
leaving the fine-scale architecture of most common SVs unknown.
Sequence data generated by the 1000 Genomes Project (1000GP) provide an unprecedented 
opportunity to generate a comprehensive SV map. The 1000GP recently generated 4.1 
Terabases of raw sequence in pilot projects targeting whole human genomes33 
(Supplementary Table 1). These studies comprise a population-scale project, termed ‘low-
coverage project’, in which 179 unrelated individuals were sequenced with an average 
coverage of 3.6X – including 59 Yoruba individuals from Nigeria (YRI), 60 individuals of 
European ancestry from Utah (CEU), 30 of Han ancestry from Beijing (CHB), and 30 of 
Japanese ancestry from Tokyo (JPT; the latter two were jointly analyzed as JPT+CHB). In 
addition, a high-coverage project, termed the ‘trio project’, was carried out, with individuals 
of a CEU and a YRI parent-offspring trio sequenced to 42X coverage on average.
We report here the results of analyses undertaken by the Structural Variation Analysis 
Group of the 1000GP. The group’s objectives were to discover, assemble, genotype, and 
validate SVs of 50 bp and larger in size, and to assess and compare different sequence-based 
SV detection approaches. The focus of the group was initially on deletions, a variant class 
often associated with disease9, for which rich control datasets and diverse ascertainment 
approaches exist1,13,22,28. Less focus was placed on insertions and duplications34 and 
none on balanced SV forms (such as inversions). Specifically, we applied nineteen methods 
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to generate an SV discovery set. We further generated reference genotypes for most 
deletions, assessed the SVs’ functional impact, and stratified SV formation mechanism with 
respect to variant size and genomic context.
Prediction of SV candidate loci and assessment of discovery methods
We incorporated the SV discovery methods into a pipeline (Fig. 1AB), with the goal of 
ascertaining different SV types and assessing each method for its ability to discover SVs. 
The methods detected SVs by analyzing RD, RP, SR, and AS features, or by combining RP 
and RD features (abbreviated as ‘PD’). Altogether we generated thirty-six SV callsets by 
applying the methods on trio and low-coverage data, and by identifying SVs as genomic 
differences relative to a human reference, corresponding to the reference genome, or to a set 
of individuals (i.e. population reference; Supplementary Table 2). We initially identified 
SVs as deletions, tandem duplications, novel sequence insertions, and mobile element 
insertions (MEIs) relative to the human reference. Subsequent comparative analyses 
involving primate genomes enabled us to classify SVs as deletions, duplications, or 
insertions relative to inferred ancestral genomic loci, reflecting mechanisms of SV formation 
(see below). DNA reads analyzed by SV discovery methods were initially mapped to the 
human reference genome using a variety of alignment algorithms. Most of these algorithms 
mapped each read to a single genomic position, although one algorithm (mrFAST16) also 
considered alternative mapping positions for reads aligning onto repetitive regions (see 
Supplementary Tables 2-4 for method-specific parameters and full SV callsets). We filtered 
each callset by excluding SVs <50bp, which are reported elsewhere33. Many SVs exhibited 
support from distinct SV discovery methods, as exemplified by a common deletion, 
previously associated with body-mass index35 (BMI), that we identified with RP, RD, and 
SR methods (Fig. 1C). Nonetheless, we observed notable differences between methods (Fig. 
2ABC) in terms of genomic regions ascertained (Supplementary Fig. 1), accessible SV size-
range (Fig. 2A), and breakpoint precision (Fig.2C, Supplementary Fig. 2).
To estimate callset specificity, we carried out extensive validations (Methods), including 
PCRs for over 3,000 candidate loci, and microarray data analyses for 50,000 candidate loci 
(Supplementary Tables 3, 4; Supplementary Fig. 3). We combined PCR and array-based 
analysis results to estimate false discovery rates (FDRs), and found that eight callsets (three 
deletion, four insertion, and one tandem duplication callset) met the pre-specified specificity 
threshold33 (FDR≤10%), whereas the other callsets yielded lower specificity (FDRs of 
13%-89%).
We further assessed the sensitivity of deletion discovery methods by collating data from four 
earlier surveys1,13,22,28 into a gold standard (Methods, Supplementary Tables 5, 6, and 
Supplementary Fig. 4A), and specifically assessing the detection sensitivity for an individual 
sequenced at high-coverage (NA12878) as well as for an individual sequenced at low-
coverage (NA12156). Unsurprisingly, given the typical trade-off between sensitivity and 
specificity, in the trios the highest sensitivities were achieved by RD and RP methods with 
FDR>10% (Fig. 2B). By comparison, in the low-coverage data, the individual method with 
the greatest accuracy (FDR=3.7%) was the second most sensitive based on our gold standard 
(Fig. 2B), and the most sensitive when expanding the gold standard to a larger set of 
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individuals (Supplementary Fig. 4B). This method, Genome STRiP (to be described 
elsewhere36), integrated both RP and RD features (PD), implying that considering different 
evidence types can improve SV discovery.
Construction of a high-confidence SV discovery set
To construct our SV discovery set (“release set”), we joined calls from different discovery 
methods corresponding to the same SV with a merging approach that was aware of each 
callset’s precision in SV breakpoint detection (Supplementary Fig. 5 and Methods). Most 
SVs in the release set (61%) were contributed by individual methods meeting the pre-
defined specificity threshold (FDR≤10%). The remaining 39% of calls were contributed by 
lower specificity methods following experimental validation. Altogether, the release set 
comprised 22,025 deletions, 501 tandem duplications, 5,371 MEIs, and 128 non-reference 
insertions (Table 1, Supplementary Table 7). With our gold standard we estimated an overall 
sensitivity of deletion discovery of 82% in the trios, and 69% in low-coverage sequence 
(Fig. 2B) using a 1 bp overlap criterion. When instead applying a stringent 50% reciprocal 
overlap criterion for sensitivity assessment (which required SV sizes inferred on different 
experimental platforms to be in close agreement) our sensitivity estimates decreased by 12% 
and 18%, respectively, in trio and low-coverage sequence (Supplementary Table 8). We 
further examined an alternative approach that involved the pairwise integration of deletion 
discovery methods, and tested its ability to discover SVs without relying on the inclusion of 
lower specificity calls following experimental validation (“algorithm-centric set”; Fig. 1B). 
While this alternative approach resulted in an increased number (by ~13%) of high-
specificity (FDR<10%) calls compared to the release set (Supplementary Text), it overall 
resulted in fewer SV calls owing to its decreased sensitivity at the lower (<200bp) SV size 
range. In the following analyses we thus focused on the release set.
Extent and impact of our SV discovery set
We next assessed the extent and impact of our SV discovery (release) set. The median SV 
size was 729 bp (mean=8 kb), approximately four times smaller than in a recent tiling CGH 
based study1, reflecting the high resolution of DNA sequence based SV discovery. We also 
compared our set to a recent survey of SVs in an individual genome37 based on capillary 
sequencing and array-based analyses24, and observed a similar size distribution for 
deletions, but differences in the size distributions of other SV classes, reflecting underlying 
differences in SV ascertainment (Supplementary Fig. 6). By comparing our SVs to databases 
of structural variation and to additional personal genome datasets, we classified 15,556 SVs 
in our set as novel, with an enrichment of low frequency SVs and small SVs amongst the 
novel variants (Methods and Supplementary Text).
A major advantage of sequence-based SV discovery is the nucleotide resolution mapping of 
SVs. We initially mapped the breakpoints of 7,066 deletions and 3,299 MEIs using SR and 
AS features. Using the TIGRA-targeted assembly approach38 we further identified the 
breakpoints of an additional 4,188 deletions and 160 tandem duplications, initially 
discovered by RD, RP, and PD methods (Methods, Supplementary Table 2). Altogether, we 
mapped ~15,000 SVs at nucleotide resolution, 48% of which were novel. Few deletion loci 
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(4.4%) displayed different SV breakpoints in different samples, which is explainable by rare 
TIGRA misassemblies, or alternatively, by recurrently formed, multi-allelic SVs 
(Supplementary Text). TIGRA further enabled us to validate an additional 7,359 SVs 
discovered with RP or RD features by identifying the SVs’ breakpoints (Methods), and to 
evaluate the mapping precision of SV discovery methods (Fig. 2C, Supplementary Figure 2).
We further assessed the putative functional impact of SVs in our set by relating them to 
genomic annotation. Seventeen hundred SVs affected coding sequences, resulting in full 
gene overlaps or exon disruptions (Table 2), many of which led to out-of-frame exons 
(Supplementary Table 9). We related gene disruptions to gene functions, and observed 
significant enrichments for several functional categories including cell defense and sensory 
perception (Supplementary Table 10). High levels of structural variation, including copy-
number variation, were previously described for both processes15,22,39. These SVs might 
be maintained in the population by selection for the purpose of functional redundancy. 
While most SVs intersecting with genes were deletions, several validated tandem 
duplications and MEIs also intersected with coding sequences (Table 2).
Population genetic properties of deletions
We next sought to generate genotypes for deletions discovered in the 1000GP data, both to 
facilitate population genetics analyses and to make our SV set amenable to association 
studies in the form of a reference genotype set. In this regard, the Genome STRiP36 
genotyping method was developed, a method combining information from RD, RP, SR and 
haplotype features of population-scale sequence data for genotyping (Methods, 
Supplementary Text). Using this approach we generated genotypes for 13,826 autosomal 
deletions in 156 individuals. The genotypes displayed 99.1% concordance with CGH array1 
based genotypes (available for 1,970 of the deletions), suggesting high genotyping accuracy.
Fig. 3 presents allele frequency analyses based on these genotypes. As expected, common 
polymorphisms (minor allele frequency (MAF) >5%) were generally shared across 
populations, while rare alleles were frequently observed in only one population (Figs. 
3ABC). We observed several candidates for monomorphic deletions (i.e., genomic segments 
putatively deleted in all individuals), explainable by rare insertions present in the reference 
genome or by remaining genotyping inaccuracies (Supplementary Text).
We next assessed the allele frequencies of gene deletions (Fig. 3D). Similar to a recent 
array-based study1, we observed a depletion of high frequency alleles among deletions 
intersecting with protein-coding sequence compared to other deletions (P=1.1×10−11; KS 
test), consistent with purifying selection keeping most gene deletions at low frequency. 
Nonetheless, several coding sequence deletions were observed with high allele frequency 
(>80%). Most of these occurred in regions annotated as segmental duplications, consistent 
with lessened evolutionary constraintin functionally redundant gene categories22. 
Intriguingly, common gene deletions also affected many unique genes with no obvious 
paralogs. We further analyzed the abundance of gene deletions in different populations and 
observed highly differentiated loci, albeit with no statistically significant relationship 
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between differentiation and particular categories of gene overlap, i.e., intronic vs. exonic 
(Supplementary Text).
By comparing deletion genotypes with genotypes of nearby SNPs, we found, consistent with 
earlier studies1,13,40, that deletions in genomic regions accessible to short read sequencing 
display extensive linkage disequilibrium (LD) with SNPs. 81% of common deletions had 
one or more SNPs with which they are strongly correlated (r2>0.8; Supplementary Fig. 7). 
This suggests that many deletions mapped in our study will be identifiable through tagging 
SNPs in future studies (Supplementary Text). On the other hand, a fifth of the genotyped 
deletions were not tagged by HapMap SNPs (a figure similar to the fraction of SNPs that are 
not tagged by HapMap SNPs41), implying that these SVs should be genotyped directly in 
association studies. Furthermore, the LD properties of complex SVs (e.g., multiallelic SV) 
have not yet been fully ascertained as methods for genotyping such SVs with similar 
accuracy still being developed.
SV formation mechanism analysis
Nucleotide resolution breakpoint information enables inference of SV formation 
mechanisms15,22. Recent studies broadly distinguished between several germline 
rearrangement classes, some of which may comprise more than one SV formation 
mechanism15,22,42,43: non-allelic homologous recombination (NAHR), associated with 
long sequence similarity stretches around the breakpoints; rearrangements in the absence of 
extended sequence similarity (abbreviated as “non-homologous” or NH), associated with 
DNA repair by non-homologous end-joining (NHEJ) or with microhomology-mediated 
break-induced replication (MMBIR); the shrinking or expansion of variable number of 
tandem repeats (VNTRs), frequently involving simple sequences, by slippage; and MEIs. 
We distinguished among the classes NAHR, NH, VNTR, and MEI by examining the 
breakpoint junction sequence of SVs initially discovered as deletions or tandem duplications 
relative to a human reference.
We first compared the SVs to orthologous primate genomic regions to distinguish deletions 
from insertions/duplications with respect reconstructed ancestral loci using the BreakSeq 
classification approach43. This analysis showed that of the 11,254 nucleotide-resolution 
SVs discovered as deletions relative to a human reference, 21% actually represented 
insertion and 2% represented tandem duplications relative to the putative ancestral genome. 
Of the remaining SVs, 60% were classified as deletions relative to ancestral sequence, 
whereas the ancestral state of 17% was undetermined. By comparison, out of 160 
nucleotide-resolution SVs identified as tandem duplications relative to the reference 
genome, 91.6% were classified as duplications relative to the ancestral genome, whereas the 
ancestral state of 8.4% remained undetermined (Supplementary Text). Our breakpoint 
analysis revealed that 70.8% of the deletions and 89.6% of the insertions exhibited 
breakpoint microhomology/homology ranging from 2-376 bp in size, with distribution 
modes of 2 bp (attributable to NH) and 15 bp (attributable to MEI), respectively (Fig. 4A, 
Supplementary Text). As expected42, a small portion of the deletions (16.1%) displayed 
non-template inserted sequences at their breakpoint junctions. By comparison, the tandem 
duplications showed extensive stretches displaying ≤95% sequence identity at the 
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breakpoint linearly correlating in lenght with SV size (Fig. 4A). In addition, most tandem 
duplications displayed 2-17 bp of microhomology at the breakpoint junctions 
(Supplementary Text).
We subsequently applied BreakSeq43 to infer formation mechanisms for all SVs classified 
with regard to ancestral state. Using BreakSeq, we inferred NH as the dominating deletion 
mechanism, and MEI as the dominating insertion mechanism (Fig. 4BC, Supplementary 
Table 11). Furthermore, an abundance of microhomology at tandem duplication breakpoints 
suggested frequent formation of this SV class by a rearrangement process acting in the 
absence of homology (NH). When relating SV formation to the variant size spectrum, we 
observed marked insertion peaks for MEIs at 300 bp, corresponding to Alu elements, and at 
6 kb, corresponding to L1/LINEs (Fig. 4C). By comparison, NH and NAHR based 
mechanisms occurred across a wide size-range, whereas VNTR expansion/shrinkage, 
consistent with earlier findings1, led to relatively small SV sizes (Figs. 4C,D).
Furthermore, when displaying the genomic distribution of SVs (Fig. 5A), we observed a 
notable clustering of SVs into ’SV hotspots’. We analyzed this clustering in detail by 
examining the distribution of non-overlapping, adjacent SVs, and observed a marked 
clustering of SVs formed by NAHR, VNTR, and NH, respectively, a signal extending to 
hundreds of kilobases (Fig.5B). The clustering was influenced by an abundance of VNTR 
near the centromeres43 and NAHR near the telomeres (Fig.5A). A significant enrichment of 
NAHR near recombination hotspots (P=1.3e-15) and segmental duplications (P=3.1e-17) 
further contributed to the clustering (Supplementary Table 13).
To further explore this clustering we devised a segmentation approach for predicting SV 
hotspots (Methods), which yielded a map of 51 putative SV hotspots (Supplementary Table 
14). 80% of the hotspots mainly comprised SVs originating from a single formation 
mechanism (Fig. 5C). Most of these corresponded to NAHR hotspots, although hotspots 
dominated by NH and VNTR also were evident. These observations suggest that SV 
formation is frequently associated with the locus-specific propensity for genomic 
rearrangement.
Conclusions and discussion
By generating an SV set of unprecedented size along with breakpoint assemblies and 
reference genotypes, we demonstrate the suitability of population-scale sequencing for SV 
analysis. Nucleotide resolution data allow the construction of reference datasets and make 
SVs readily assessable across different experimental platforms using genotyping 
approaches. Our fine-scale map enabled us to examine the functional impact of SVs, as 
exemplified by our analysis of gene disruption variants, which will be of value for genome 
and exome sequencing studies.
Our map further enabled us to examine size spectra of SV formation mechanisms and led us 
to identify genomic SV hotspots that are commonly dominated by a single formation 
mechanism. Recurrent rearrangements, implicated in genomic disorders, are hypothesized to 
be associated with local genome architecture44, e.g., with segmental duplications that 
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facilitate NAHR. Also, DNA rearrangement in the absence of homology, i.e., MMBIR, has 
been implicated in recurrent SV formation8,45. In this regard, we noticed that out of the 
hotspots we report, six fall into critical regions of known genetic disorders associated with 
recurrent de novo deletions, including Miller-Dieker syndrome and Leri-Weill 
dyschondrosteosis (Supplementary Table 14). Irrespective of potential disease relevance, or 
inferred mechanism of formation, our analysis revealed a map of SV hotspots that may 
constitute local centers of de novo SV formation, consistent with the concept that local 
genome architecture contributes to genomic instability44.
Our study focused on characterizing deletions, which are often associated with disease9. 
Facilitated by ancestral analyses of SV loci, we also characterized insertions and tandem 
duplications, albeit in less detail than deletions. Companion papers with more detailed 
analyses of MEIs, and copy-number variation within segmental duplications are published 
elsewhere34,46. Of note, most SV discovery methods depend on mapping reads onto their 
genomic locus of origin, i.e., the ‘accessible’ fraction of the genome, a fraction lessened in 
segmental duplications that are of high interest to SV analysis. Nonetheless, owing to the 
abilities of RP and RD methods in detecting SVs in these regions and in interpreting reads 
with multiple mapping positions, the ‘accessible’ fraction of the genome is higher for SVs 
than for SNPs16. In the future, sequencing technologies generating longer DNA reads will 
increase the accessible genome, and will enable the assessment of SVs embedded in long 
repeat structures, such as balanced inversions.
Our SV resource will enable the discovery, genotyping, and imputation of SVs in larger 
cohorts. Numerous genomes will be sequenced in the coming months to facilitate disease 
association studies. Systematic characterization of SVs in these genomes will benefit from 
the concepts and datasets presented here.
Methods Summary
Samples
Sequence data for 179 unrelated individuals and six individuals from parent-offspring trios 
were obtained as part of the 1000GP. These data were generated with Illumina/Solexa, 
Roche/454, and Life Technologies/SOLiD sequencing technology platforms.
SV discovery and breakpoint assembly
The SV discovery methods we applied comprised six RP, four RD, three SR, four AS, and 
two PD based methods. TIGRA38 was used for targeted breakpoint assembly.
Experimental validation
We validated SV calls by PCR, array CGH and SNP microarrays, targeted assembly, and 
custom microarray-based sequence capture. PCR was performed in various different 
laboratories33, CGH analysis was performed based on tiling array data provided by the 
Genome Structural Variation Consortium (ArrayExpress: E-MTAB-40), and SNP array 
analysis based on data obtained from the International HapMap Consortium (http://
hapmap.ncbi.nlm.nih.gov).
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Genotyping
Genome STRiP36 was used for deletion genotyping in low coverage sequence data. Initial 
genotype likelihoods were derived with a Bayesian model and imputation into a SNP 
genotype reference panel from the HapMap41 (Hapmap3r2) was achieved with Beagle 
(v3.1; http://faculty.washington.edu/browning/beagle/beagle.html).
SV formation mechanism analysis
SV breakpoints mapped at nucleotide resolution were analyzed with BreakSeq43 to classify 
SVs relative to putative ancestral loci and to infer SV formation mechanisms. SV hotspots 
were mapped with custom Perl and R scripts.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SV discovery and genotyping in population scale sequence data
A. Schematic depicting the different modes (i.e., approaches) of sequence based SV 
detection we used. The RP approach assesses the orientation and spacing of the mapped 
reads of paired-end sequences14,15 (reads are denoted by arrows); the RD approach 
evaluates the read depth-of-coverage25,26; the SR approach maps the boundaries 
(breakpoints) of SVs by sequence alignment28,29; the AS approach assembles SVs30,31,32. 
B. Integrated pipeline for SV discovery, validation, and genotyping. Colored circles 
represent individual SV discovery methods (listed in Supplementary Table 1), with modes 
indicated by a color scheme: green=RP; yellow=RD; purple=SR; red=AS; green and 
yellow=methods evaluating RP and RD (abbreviated as ‘PD’). C. Example of a deletion, 
previously associated with BMI35, identified independently with RP (green), RD (yellow), 
and SR (red) methods. Grey dots indicate position and mapping quality for individual 
sequence reads. Targeted assembly confirmed the breakpoints detected by SR.
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Figure 2. Comparative assessment of deletion discovery methods
A. Deletion size-range ascertained by different modes of SV discovery. Three groups are 
visible, with AS and SR, PD and RP, as well as RD and ‘RL’ (RP analysis involving 
relatively long range (≥1 kb) insert size libraries, resulting in a different deletion detection 
size range compared to the predominantly used <500kb insert size libraries), respectively, 
ascertaining similar size-ranges. Pie charts display the contribution of different SV 
discovery modes to the release set. Outer pie = based on number of SV calls; inner pie = 
based on total number of variable nucleotides. Of note, not all approaches were applied 
across all individuals (see Supplementary Table 2). B. Sensitivity and FDR estimates for 
individual deletion discovery methods based on gold standard sets for individuals sequenced 
at high (NA12878) and low-coverage (NA12156), respectively. All depicted estimates are 
summarized in Supplementary Tables 3, 4, 6. Vertical dotted lines correspond to the 
specificity threshold (FDR≤10%). C. Breakpoint mapping resolution of three deletion 
discovery methods (the respective method names are in Supplementary Table 2). The blue 
and red histograms are the breakpoint residuals for predicted deletion start and end 
coordinates, respectively, relative to assembled coordinates (here assessed in low-coverage 
data). The horizontal lines at the top of each plot mark the 98% confidence intervals (labeled 
for each panel), with vertical notches indicating the positions of the most probable 
breakpoint (the distribution mode).
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Figure 3. Analysis of deletion presence and absence in two populations
A-C. Deletion allele frequencies and observed sharing of alleles across populations, 
displayed for deletions discovered in the CEU, YRI, and JPT+CHB population samples in 
terms of stacked bars. D. Allele frequency spectra for deletions intersecting with intergenic 
(blue), intronic (yellow), and protein-coding sequences (red).
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Figure 4. Contribution of SV formation mechanisms to the SV size spectrum
A. Breakpoint junction homology/microhomology length plotted as a function of SV size for 
SVs originally identified as deletions compared to a human reference. Dots are colored 
according to the SVs’ classification as deletions, insertions/duplications, or “undetermined” 
relative to inferred ancestral genomic loci. Gray lines mark groups of SVs likely formed by 
a common formation mechanism. The diagonal highlights tandem duplications (and few 
reciprocal deletion events), in which the length of the duplicated sequence correlates linearly 
with the length of the longest breakpoint junction sequence identity stretch. The ellipses 
indicate MEIs, i.e., Alu (~300 bp) and L1 (~6 kb) insertions, associated with target site 
duplications of up to 28 bp in size at the breakpoints. The horizontal group corresponds 
mostly to NH-associated deletions with <10 bp microhomology at the breakpoints. The 
remaining (ungrouped) SVs comprise truncated MEIs, VNTR expansion and shrinkage 
events, as well as NAHR-associated deletions and duplications. B. Relative contributions of 
SV formation mechanisms in the genome. Numbers of SVs are displayed on the outer pie 
chart and affected base pairs on the inner. Left panel: SVs classified as deletions relative to 
ancestral loci. Right panel: SVs classified as insertions/duplications. C. Size spectra of 
deletions classified relative to ancestral loci. D. Size spectra of insertions/duplications.
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Figure 5. Mapping hotspots of SV formation in the genome
A. Distribution of SVs on chromosome 10 (“chr10”). Above the ideogram, colored bars 
indicate SV formation mechanisms (same color scheme as in B and C); bar lengths relate to 
the logarithm of SV size. Below the ideogram, bar lengths are directly proportional to allele 
frequencies. Arrows indicate an SV hotspot near the centromere underlying mainly VNTR, 
and several hotspots near the telomeres underlying mainly NAHR events. B. Enrichment of 
SVs inferred to be formed by the same formation mechanism for different genomic window 
sizes. Displayed is an enrichment of nearby, non-overlapping SVs formed by the same 
mechanism relative to an SV set where mechanism assignments are shuffled randomly. C. 
SV hotspots are mostly dominated by a single formation mechanism. Colored bars depict 
numbers of SV hotspots in which at least 50% of the variants were inferred to be formed by 
a single formation mechanism. The average abundance of NAHR-classified SVs in NAHR 
hotspots was 70% (compared with 77% for VNTR-hotspots; 69% for NH). The gray bar 
(“mixed”) corresponds to SV hotspots with no single mechanism dominating.
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